The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.
 
Huiyan Luo
No Relationships to Disclose
 
Pansong Li
No Relationships to Disclose
 
Wei Wei
No Relationships to Disclose
 
Yong-Bin Lin
No Relationships to Disclose
 
Hong Yang
No Relationships to Disclose
 
Han Yang
No Relationships to Disclose
 
Kong-Jia Luo
No Relationships to Disclose
 
Xiaoman Hu
No Relationships to Disclose
 
Haibo Qiu
No Relationships to Disclose
 
Shu-Qiang Yuan
No Relationships to Disclose
 
Yuan-fang Li
No Relationships to Disclose
 
Xiao-Jun Lin
No Relationships to Disclose
 
Bo-kang Cui
No Relationships to Disclose
 
Li Xu
No Relationships to Disclose
 
Rong-Xin Zhang
No Relationships to Disclose
 
Wenhua Fan
No Relationships to Disclose
 
Chunyan Lan
No Relationships to Disclose
 
Ting Wan
No Relationships to Disclose
 
Qi-hua Zhang
No Relationships to Disclose
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; CPPC; Hengrui Pharm; Hutchison MediPharma; Innovent Biologics; Junshi Pharmaceuticals; Keymed Biosience; Merck Serono; MSD; QiLu Pharmaceutical; Roche